Dietary Intake Is Associated with Phthalate Body Burden in a Nationally Representative Sample by Colacino, Justin A. et al.
998  v o l u m e  118 | n u m b e r 7 | July 2010  •  Environmental Health Perspectives
Research
Phthalates are a family of chemicals that have 
been approved for use in a wide range of con­
sumer products, including building materials, 
personal cosmetics, pharmaceuticals, nutritional 
supplements, solvents, adhesives, paints, lac­
quers, insecticides, cleaning materials, children’s 
toys, and food packaging (Schettler 2006). The 
annual global use of phthalates is estimated to 
exceed 3 million metric tons per year (Schettler 
2006). Phthalates have been used for > 50 years 
to increase the plasticity of rigid materials such 
as polyvinyl chloride (PVC).
Toxicological studies of phthalates and 
related compounds have established potential 
health effects of exposure, particularly endo­
crine disruption. In animal studies, researchers 
have found an association between phthalate 
exposure and the induction of testicular toxicity 
in rats and guinea pigs as well as male repro­
ductive tract lesions such as seminiferous epi­
thelial degeneration (Barlow et al. 2004; Gray 
et al. 1982). Phthalate exposure also has effects 
on the female reproductive system, includ­
ing decreased estradiol production, prolonged 
estrous cycles, and no ovulation in adult rats 
(Davis et al. 1994; Lovekamp­Swan and Davis 
2003). In a three­generation phthalate exposure 
study, Pereira et al. (2007) found significant 
increases in liver enzymes [alanine aminotrans­
ferase (ALT) and aspartate aminotransferase 
(AST)] over the three generations and decreases 
in serum cholesterol, liver glutathione, and 
glutathione reductase, especially in the F2 
generation. Effects on sexual health and devel­
opment have been observed in recent human 
studies. Phthalate exposure was associated with 
decreased anogenital distance in male infants, 
which was found to be significantly correlated 
with penile volume and cryptorchidism (Swan 
et al. 2005). A study using the National Health 
and Nutrition Examination Survey (NHANES) 
data from 1999–2002 found an association 
between urinary phthalate metabolites and 
increased waist circumference and insulin 
resistance (Stahlhut et al. 2007). Additionally, 
increased phthalate body burden, particularly 
of one metabolite, mono­2­ethylhexyl phtha­
late (MEHP), was associated with decreases in 
testosterone and estradiol in adult men (Meeker 
et al. 2009). Levels of phthalates in house dust 
have been associated with rhinitis, eczema, and 
asthma in humans (Bornehag et al. 2004).
Typically, phthalate body burden is esti­
mated through measurement of phthalate 
metabolites in the urine. The half­life of the 
parent phthalates is very short, and high lev­
els of contamination in laboratories present 
technical difficulties when analyzing for phtha­
lates (Lorber et al. 2010). Silva et al. (2004), 
assessed body burdens of phthalate metabo­
lites for a portion of the U.S. population in 
NHANES. In this study, they found that chil­
dren had significantly higher levels of certain 
phthalate metabolites, monobutyl phthalate, 
monobenzyl phthalate (MBzP), and MEHP 
than did adults; however, they had significantly 
lower levels of monoethyl phthalate (MEP), 
likely because of the use of MEP in consumer 
products such as cosmetics, which are used 
more by adults than by children. Another 
study compared the levels of phthalate metab­
olites in infants and their mothers and found 
that, on average, creatinine­adjusted levels of 
phthalate metabolites were higher in infants 
than in their mothers (Sathyanarayana et al. 
2008). Creatinine adjustment has been used 
to normalize excretion of phthalate metabo­
lites and many other contaminants (Jackson 
1966). Given a daily rate of elimination of 
creatinine, one can estimate a full day’s elimi­
nation of the phthalate metabolite. With other 
considerations, this daily elimination can be 
used to estimate the intake that may have been 
associated with this measurement. A study of 
a Danish–Finnish cohort of mothers found 
phthalate metabolites in all samples of breast 
milk that were tested (Main et al. 2006).
Phthalates have been used widely as plas­
ticizers in food packaging, and as such, diet is 
considered a major route of exposure (Schettler 
2006). Research on the levels of phthalates in 
food is limited because the accurate determi­
nation of phthalate levels by a laboratory is 
severely complicated by the ubiquitous nature 
of phthalate contamination (Fromme et al. 
2007). Phthalates have been measured previ­
ously in NHANES, beginning in NHANES 
III, where levels of phthalate metabolites were 
measured in samples collected from 289 adults 
in 1988–1994 (Blount et al. 2000), to more 
recent studies that have greatly expanded 
the sample population [Centers for Disease 
Control and Prevention (CDC) 2005, 2009; 
Silva et al. 2004].
Although research suggests that dietary 
intake is a significant route of exposure for 
phthalates, because of elevated levels detected 
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Ba c k g r o u n d: Phthalates are compounds that are used in a wide range of consumer products. 
However, the contribution of dietary intake to phthalate exposure has not been well defined. 
oB j e c t i v e: The objective of this study was to assess the contribution of different food types to 
phthalate exposure. Phthalates are chemicals of concern because of the high levels measured in 
people and the environment, as well as the demonstrated toxicity in animal studies and limited epi­
demiological studies. Previous research, although limited, has suggested that phthalates contaminate 
food in various countries.
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National Health and Nutrition Examination Survey (NHANES). Associations between dietary 
intake (assessed by a 24­hr dietary recall) for a range of food types (meat, poultry, fish, fruit, veg­
etable, and dairy) and phthalate metabolites measured in urine were analyzed using multiple linear 
regression modeling.
re s u l t s: We found that metabolites of di­(2­ethylhexyl) phthalate (DEHP) and high­molecular­
weight phthalate metabolites were associated with the consumption of poultry. Monoethyl 
phthalate, the metabolite of diethyl phthalate (DEP), was associated with vegetable consumption, 
specifically tomato and potato consumption.
discussion: These results, combined with results from previous studies, suggest that diet is an 
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in food samples (Fromme et al. 2007; 
Tsumura et al. 2001, 2003), few research 
studies have been conducted to quantify how 
dietary intake correlates with body burden of 
these toxic chemicals.
The primary aim of this study was to ana­
lyze the relationship between meat, dairy, 
fish, fruit, and vegetable consumption and 
total phthalate body burden in the United 
States using data from NHANES 2003–2004 
(CDC 2010), an ongoing health and nutri­
tion survey of the U.S. population. The sec­
ondary aim of this study was to analyze the 
relationship between meat, dairy, fish, fruit 
and vegetable consumption and body burden 
of individual phthalate metabolites, as well 
as the sums of metabolites of high­ and low­
molecular­weight phthalates.
Materials and Methods
Data set. The NHANES is an ongoing survey 
of the civilian, noninstitutionalized U.S. pop­
ulation designed to monitor the health status 
of adults and children [Centers for Disease 
Control and Prevention (CDC) 2010]. The 
survey combines questionnaire data with 
physical examinations as well as biomoni­
toring of chemical contaminants in blood 
and urine. NHANES is administered by the 
National Center for Health Statistics, and the 
biomonitoring is performed by the National 
Center for Environmental Health, both divi­
sions of the CDC.
NHANES typically samples around 
5,000 individuals each year using a complex, 
multistage probability sampling design with 
oversampling of populations that might be at 
greater health risk. Although data are collected 
continuously, data sets are reported in 2­year 
cycles to ensure that the sample size is suf­
ficiently large. In the NHANES 2003–2004 
survey, phthalate metabolites were measured 
in urine from 2,697 individuals ≥ 6 years old. 
Data for both measurements of phthalate 
metabolites and dietary intake were available 
for 2,374 individuals. There was no significant 
difference in age or sex between the individu­
als who had dietary intake data and those who 
did not. The proportion of white individuals 
was higher in the group that had dietary data 
than in the group that did not.
Dietary intake. Dietary intake was assessed 
in NHANES using two 24­hr dietary recall 
face­to­face interviews, a 24­hr dietary recall 
conducted by telephone 3–10 days after the 
interview, and a food frequency questionnaire. 
Instructions for the interviews were provided 
orally during the first interview session in 
English, Spanish, or both languages. During 
both reporting sessions, information related to 
types of foods and beverages consumed, por­
tions, and meal times was collected. The 24­hr 
dietary recall questionnaire gathered informa­
tion about food type and portions consumed, 
and the food frequency questionnaire asked 
about frequency of food consumption but not 
about portion size. The food frequency ques­
tionnaire was distributed to enrolled partici­
pants who completed at least one 24­hr dietary 
recall interview. Because of the short half­life 
of phthalates in the human body, which are 
estimated to be on the order of hours, dietary 
intake was estimated using only the first 24­hr 
dietary recall, which assessed dietary intake for 
the day before urine was collected for phthalate 
measurements.
The individual foods measured in the 
dietary intake interview were grouped based on 
the MyPyramid equivalents [U.S. Department 
of Agriculture­Agricultural Research Service 
(USDA­ARS) 2010]. The groups of interest for 
this analysis were milk, meat and beans, vegeta­
bles, and fruit. Subgroups of interest were total 
dairy foods (milk, yogurt, and cheese); meat 
(beef, pork, veal, lamb, and game); frankfurt­
ers, sausage, and luncheon meats (made from 
meat or poultry); poultry (chicken, turkey, and 
other); fish and shellfish high in n­3 fatty acids; 
fish and shellfish low in n­3 fatty acids; eggs; 
vegetables; legumes; and fruit.
Chemical analyses. Chemical analyses of 
phthalates were conducted as reported previ­
ously (Kato et al. 2005; Sjodin et al. 2004). 
Phthalate metabolites are reported individu­
ally in the NHANES data set. Any phthalate 
metabolites that were detected in fewer than 
60% of the samples were excluded from future 
analyses, because of the inability to calculate 
geometric means for these congeners, as has 
been reported previously in NHANES analyses 
(Sjodin et al. 2008). Total phthalate metabo­
lite levels were calculated for each individual 
by summing the levels of the analytes that met 
this condition. Levels that were below the limit 
of detection were estimated by dividing the 
limit of detection for that specific analyte by 
the square root of two. Additionally, high­ and 
low­molecular­weight phthalate metabolite 
totals were calculated, because low­ and high­
molecular­weight phthalates are used in dif­
ferent classes of commercial products and thus 
may represent different routes of exposure. 
Low­molecular­weight phthalates are defined 
as those with molecular weight < 250 g/mol 
(Wolff et al. 2008). Additionally, associations 
between the sum of the four di­(2­ethylhexyl) 
phthalate (DEHP) metabolites [mono­2­ethyl­
5­carboxypentyl phthalate (MECPP); mono­
(2­ethyl­5­hydroxyhexyl) (MEHHP); MEHP; 
and mono­(2­ethyl­5­oxohexyl) phthalate 
(MEOHP)] and dietary intake were also cal­
culated. Phthalate metabolites were analyzed 
on a creatinine­adjusted basis.
Demographic variables. The demographic 
variables we analyzed included age, sex, ethnic­
ity, and body mass index (BMI; the weight 
of an individual in kilograms divided by the 
square of their height in meters). A BMI of 
< 18.5 is considered underweight, 18.5–25 
is considered normal weight, 25–30 is over­
weight, and > 30 is obese. In the multiple 
regression analyses used in this study, we 
treated BMI as a continuous variable.
Data analysis. Food consumption, using 
the MyPyramid equivalents (USDA­ARS 
2010), was correlated with total phthalate 
metabolite concentrations, total low and high­
molecular­weight phthalate metabolite con­
centrations, and levels of individual phthalate 
metabolites. Three stages of data analyses were 
conducted. First, preliminary (or univariate) 
analysis was conducted to find mean, median, 
and ranges of the sample’s demographics, 
dietary characteristics, and body burden of 
phthalate metabolites based on sample weights. 
Means, geometric means, and medians of indi­
vidual and total phthalate metabolites were also 
calculated based on weighted data. Phthalate 
metabolite levels were found to be highly 
skewed, thus log­transformed values of these 
variables were used in all subsequent bivariate 
and multivariable analyses.
Second, we assessed relationships between 
dietary intake of individual food types and 
measured levels of individual phthalate 
metabolites with bivariate analyses, includ­
ing correlations and bivariate linear regres­
sion models. The dependent variable in these 
analyses was a measured chemical level, that 
is, individual phthalate metabolites, low­ or 
high­molecular­weight metabolites, DEHP 
metabolites, or total metabolites. The total 
servings of one MyPyramid food subgroup 
(USDA­ARS 2010) were included in each 
model. All regression models were built using 
weighted data. Finally, for each association 
that was statistically significant in the bivariate 
analyses (p < 0.05), we constructed a multiple 
linear regression model, including that food 
type and the covariates age, BMI, sex, and 
ethnicity. Age and BMI were modeled as con­
tinuous variables, and sex and ethnicity were 
modeled categorically (Table 1).
We performed the data analysis with the 
survey procedures using SAS software (version 
9.2; SAS Institute, Cary, NC), with the appro­
priate sample characteristics (strata, clusters, 
and weights), as described in the NHANES 
documentation (CDC 2010).
Table 1. Sex and ethnicity of the study partici-
pants from the NHANES 2003–2004 data sets 
(weighted n = 2,350).
Percent
Sex
Male 48.0
Female 52.0
Ethnicity
Mexican American 8.6
Other Hispanic 4.5
Non-Hispanic white 70.7
Non-Hispanic black 11.4
Other race 4.9Colacino et al.
1000  v o l u m e  118 | n u m b e r 7 | July 2010  •  Environmental Health Perspectives
Results
Univariate analysis. Most individuals (52.4%) 
in the NHANES sample with food and 
phthalate data were female. The demographic 
distribution of the NHANES participants is dis­
played in Table 1. The age of NHANES partic­
ipants ranged from 6 to 85 years old (weighted 
mean = 39.0 years). The BMI ranged from 
13.0 to 58.6 (weighted mean = 26.8 kg/m2).   
The percentage of individuals who were clas­
sified as underweight, normal weight, over­
weight, and obese is shown in Table 2.
Table 3 presents the dietary intake of the 
food groups we analyzed. There was a wide 
range of meat consumption, from 0 ounce 
equivalents to 25.5 ounce equivalents con­
sumed. The consumption of fish and poultry 
was also quite variable, with ranges of 0–14.3 
and 0–17.7 ounce equivalents consumed, 
respectively. The median cups of fruit con­
sumed was 0.6, whereas the median consump­
tion of vegetables (excluding legumes) was 1.1.
Ten phthalate metabolites were detected 
in the urine of > 60% of the population: 
MECPP; mono‑n‑butyl phthalate (MnBP); 
mono­(3­carboxypropyl) phthalate (MCPP); 
MEP; MEHHP; MEHP; mono‑n‑methyl 
phthalate (MnMP); MeOHP; and MBzP. The 
measured levels of unadjusted phthalate metab­
olites are presented in Table 4, and the levels of   
creatinine­adjusted phthalate metabolites 
are shown in Table 5. MEP, a metabolite 
of diethyl phthalate (DEP), was detected 
at the highest concentration in the popula­
tion (geometric mean 194.4 ng/mL; range, 
3.5–46,347). Mono­(2­ethyl­5­carboxypentyl) 
phthalate (MECCP), a metabolite of DEHP, 
was detected at the next highest concen­
tration (geometric mean 35.3 ng/mL;   
range, 0.2–2,887). The sum of the low­ 
molecular­weight phthalate metabo  lites, MEP 
and MnMP, had a geometric mean of 201.8 
ng/mL (range, 4.2–46,359). The sum of the 
high­molecular­weight phthalate metabo­
lites, MECPP, MnBP, MCPP, MEHHP, 
MEHP, mono­isobutyl phthalate (MiBP), 
MEOHP, and MBzP, had a geometric mean 
of 137.4 ng/mL (range, 2.1–6,616). Total 
phthalates (the sum of both low­ and high­
molecular­weight phthalate metabolites) had 
a geometric mean of 437.9 ng/mL (range,   
8.9–47,586).
Adjusting for creatinine concentration did 
not affect which phthalate metabolites were 
detected at the highest levels. MEP still had 
the highest geometric mean concentration at 
184.3 µg/g creatinine (range, 1.9–29,986). The 
low­molecular­weight phthalates had a geo­
metric mean creatinine­adjusted concentration 
of 190.5 µg/g creatinine (range, 2.1–29,987), 
whereas the high­molecular­weight phthalates 
had a geometric mean creatinine­  adjusted 
concentration of 129.7 µg/g creatinine 
(range, 0.7–4,901). Total phthalates had a geo­
metric mean creatinine­adjusted concentration 
of 413.3 µg/g creatinine (range, 2.8–30,119).
Bivariate analysis. Scatterplots with 
LOESS curves did not show outliers or curvi­
linear relationships. Bivariate linear regres­
sion models estimated the relationship 
between consumption of single food groups 
and phthalate levels. Food types that had a 
statistically significant (p < 0.05) association 
were included in multiple regression analyses 
that adjusted for demographic covariates. The 
statistically significant results of the bivari­
ate and multiple regression analyses can be 
seen in Table 6. Nonsignificant results of 
bivariate and multiple regression analyses can 
be seen in Supplemental Material, Table 1 
(doi:10.1289/ehp.0901233). The regression 
coefficients shown describe the change in log­
transformed creatinine­adjusted phthalate 
metabolite level associated with consumption 
of one additional serving of food.
In bivariate analyses, total dairy consump­
tion was significantly associated with MCPP. 
Poultry consumption was a significant predic­
tor of levels of all of the individual DEHP 
metabolites, MEHP, MEHHP, MEOHP, 
MECCP, total DEHP metabolites, as well as 
high­molecular­weight phthalate metabolites 
and total phthalate metabolites. Egg consump­
tion was also significantly associated with uri­
nary MEHP levels. High­molecular­weight 
phthalates, particularly DEHP, are lipid 
Table 2. Percentage of individuals underweight, 
normal weight, overweight, or obese from the 
NHANES 2003–2004 data sets (weighted n = 2,350).
Weight class Percent
Underweight 9.6
Normal weight 34.1
Overweight 28.7
Obese 27.7
Table 3. Dietary intake of various food types for 
study participants in the NHANES 2003–2004 data 
sets (ounce equivalents consumed per day for 
meat, poultry, eggs, and fish; cups consumed for 
others).
Food type Mean Median SE Range
Total dairy 1.7 1.2 0.035 0–15.1
Total eggs 0.5 0.02 0.02 0–6.6
Total fisha 0.4 0 0.03 0–14.3
Total meatb 1.8 0.5 0.05 0–25.5
Total poultry 1.3 0 0.05 0–17.7
Total fruit 1.04 0.6 0.03 0–12.1
Legumes 0.13 0 0.01 0–3.9
Potato 0.4 0 0.01 0–9.0
Tomato 0.4 0.2 0.01 0–5.2
Total vegetablesc 1.4 1.1 0.02 0–11.57
aTotal fish low in omega-3 amino acids. bTotal meat from 
beef, pork, veal, lamb, and game. cTotal vegetables con-
sumed, excluding legumes.
Table 4. Unadjusted levels of phthalate metabolites (ng/mL urine) measured in the NHANES 2003–2004 
data set.
 
Limit of 
detection Median Mean SE
Geometric 
mean Range
MECPP 0.25 35.3 90.1 6.6 34.5 0.2–2,886
MnBP 0.4 25.9 43.2 5.2 20.7 0.3–5,143
MCPP 0.16 3.3 5.6 0.3 2.9 0.1–389
MEP 0.4 207.9 675.5 69.4 194.4 3.5–46,347
MEHHP 0.32 23.1 65.2 5.1 21.8 0.2–3,141
MEHP 0.90 2.1 8.1 0.9 2.3 0.6–718
MiBP 0.26 4.9 7.1 0.6 3.7 0.2–359
MnMP 1.0 1.4 5.4 0.9 1.8 0.7–1,170
MEOHP 0.45 15.9 42.4 2.9 14.4 0.4–1,953
MBzP 0.11 17.4 29.7 1.2 13.7 0.1–1,197
Low-molecular-weight metabolites 212 680.9 70.1 201.8 4.2–46,358
High-molecular-weight metabolites 157.2 291.3 17.5 137.4 2.1–6,616
Total phthalates 458 972.2 75.3 437.9 8.9–47,585
Table 5. Creatinine-adjusted levels of phthalate metabolites (µg/g creatinine) measured in the NHANES 
2003–2004 data set.
Median Mean SE
Geometric 
mean Range
MECPP 28.5 68.9 4.6 32.6 0.06–2,075
MnBP 20.7 34.0 3.5 19.6 0.09–3,596
MCPP 2.7 4.5 0.3 2.7 0.03–426
MEP 175.9 561.9 60.6 184.3 1.9–29,986
MEHHP 18.3 48.9 2.8 20.4 0.06–1,578
MEHP 1.9 6.5 0.7 2.2 0.09–294
MiBP 3.9 5.4 0.4 3.5 0.06–140
MnMP 1.5 5.0 0.8 1.7 0.2– 887
MEOHP 12.4 31.6 1.5 13.6 0.1–1,028
MBzP 13.6 22.9 0.9 12.9 0.03– 596
Low-molecular-weight metabolites 181.8 566.8 61.1 190.5 2.1–29,987
High-molecular-weight metabolites 122.3 222.6 10.6 129.7 0.7–4,901
Total phthalates 374.7 789.5 63.5 413.3 2.8–30,119Dietary intake predicts phthalate body burden
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soluble (Dickerson 1997). Despite the high fat 
content in meat, consumption was associated 
with MEP levels, the metabolite of DEP, as 
well as with low­molecular­weight phthalate 
metabolites, likely because of the association 
with MEP. Vegetable consumption was also 
significantly associated with MEP levels, which 
was one of the strongest effects measured. 
To further examine the relationship between 
vege  table intake and MEP levels, we calculated 
the association between tomato and potato 
consumption and MEP levels. Consumption 
of both of these vegetables was associated with 
MEP levels. Additionally, tomato consump­
tion was associated with low­molecular­weight 
phthalate metabolites, likely because of the 
strong association between tomato consump­
tion and MEP levels. Fruit consumption was 
associated with levels of MnMP, a metabolite 
of dimethyl phthalate, a low­molecular­weight 
phthalate. Additionally, fruit consumption 
was found to be inversely associated with high­
molecular­weight phthalate metabolites and 
DEHP metabolites. Fish consumption was 
associated with levels of MiBP, a metabolite of 
diisobutyl phthalate, a high­molecular­weight 
phthalate. Levels of MnBP were not found 
to be significantly associated with any of the 
dietary variables.
Multivariable analysis. To adjust for pos­
sible covariates that may have confounded 
the effects observed in the bivariate regres­
sion analyses, we also performed multiple 
regression analyses. In these analyses, other 
variables included in the model were age, eth­
nicity, sex, and BMI. Phthalate levels were 
previously shown to be associated with BMI 
(Hatch et al. 2008). The regression coefficient 
for the association between the log­adjusted 
creatinine­adjusted DEHP metabolites and 
poultry consumption in the multivariable 
model was 0.055, suggesting that an increase 
of one ounce of poultry per day is associated 
with an increase in DEHP metabolite levels 
of approximately 5.7%.
Discussion
This analysis demonstrates that there is an 
association between the reported consumption 
of different food types and the levels of phtha­
late metabolites in urine of study participants. 
Previous research has established that many 
commonly consumed food types are con­
taminated with persistent organic pollutants, 
although the literature is sparse for phthalate 
levels in food, because of the difficulties of 
analyzing parent phthalate compounds.
A study of homogenized duplicated diet 
samples collected over the course of 7 days 
from 50 total study subjects (27 women, 
23 men) age 14–60 years old from Germany 
found that dietary intake of DEHP was sig­
nificantly correlated with levels of DEHP 
metabolites measured in urine (Fromme et al. 
2007). The median daily intake of DEHP 
was estimated to be 2.4 µg/kg body weight 
(95th percentile estimate: 4.0 µg/kg body 
weight), whereas the median daily intake of 
di‑n‑butyl phthalate (DnBP) was estimated 
to be 0.3 µg/kg body weight (95th percen­
tile estimate: 1.4 µg/kg body weight). The 
median daily intake of di­isobutyl phthalate 
(DiBP) was estimated to be 0.6 µg/kg body 
weight (95th percentile estimate, 2.1µg/kg 
body weight). However, although DEHP 
intake was significantly correlated with lev­
els of DEHP metabolites measured in study 
participants, similar correlations were not 
observed for DnBP and DiBP metabolites. 
In the current study, creatinine­adjusted 
levels of MEHP (a metabolite of DEHP) 
were significantly associated with poultry 
consumption; total meat, poultry, and fish 
consumption; and discretionary solid fat con­
sumption in multivariate regression models. 
Creatinine­adjusted levels of another DEHP 
metabolite, MECPP, were also significantly 
associated with discretionary solid fat con­
sumption in multivariate regression models. 
Creatinine­adjusted levels of MEHHP, also 
a DEHP metabolite, were significantly asso­
ciated with poultry and discretionary solid 
fat consumption. Similar results were also 
observed for creatinine­adjusted MEOHP, a 
DEHP metabolite as well. The results from 
the Fromme et al. study (2007), as well as this 
study, point to diet as a significant route of 
exposure to DEHP, mostly likely from meat 
consumption or consumption of solid fats.
A research group from Japan examined the 
levels of phthalate esters in duplicate diet sam­
ples on two separate occasions (Tsumura et al. 
Table 6. Change of log-transformed creatinine-adjusted phthalate metabolite levels per additional ounce equivalent of meat, egg, poultry, or fish, or per cup of 
other foods, based on statistically significant bivariate and multiple regression analyses.
Dietary intake group Phthalate metabolite
Bivariate analysis Multiple regression analysisa
B (95% CI) p-Value B (95% CI) p-Value
Dairy MCPP 0.051 (0.033 to 0.069) < 0.0001 0.039 (0.021 to 0.057) 0.0003
Egg MEHP 0.13 (0.039 to 0.222) 0.0085 0.145 (0.057 to 0.232) 0.0031
Low omega-3 fish MiBP 0.037 (0.008 to 0.066) 0.016 0.04 (0.008 to 0.073) 0.0179
Meat MEP 0.035 (0.003 to 0.067) 0.0358 0.04 (0.006 to 0.073) 0.0224
Low molecular weightb 0.034 (0.001 to 0.067) 0.0418 0.039 (0.005 to 0.072) 0.0254
Poultry MEHHP 0.054 (0.028 to 0.08) 0.0006 0.046 (0.018 to 0.074) 0.0031
MEHP 0.084 (0.059 to 0.11) < 0.0001 0.08 (0.054 to 0.106) < 0.0001
MEOHP 0.054 (0.029 to 0.079) 0.0004 0.046 (0.02 to 0.073) 0.002
MECPP 0.033 (0.009 to 0.057) 0.0094 0.029 (0.003 to 0.054) 0.0325
High molecular weightc 0.029 (0.007 to 0.051) 0.0121 0.025 (0.003 to 0.047) 0.0294
DEHP metabolitesd 0.055 (0.03 to 0.081) 0.0003 0.048 (0.021 to 0.075) 0.0018
Fruit MnMP 0.067 (0.017 to 0.116) 0.0115 0.058 (0.01 to 0.106) 0.0211
MEHHP –0.069 (–0.116 to –0.022) 0.0072 –0.050 (–0.09 to –0.01) 0.0173
MEOHP –0.066 (–0.115 to –0.017) 0.0117 –0.047 (–0.09 to –0.005) 0.0309
MECPP –0.050 (–0.09 to –0.011) 0.0153 –0.035 (–0.069 to –0.001) 0.0459
MBzP –0.091 (–0.129 to –0.052) 0.0001 –0.078 (–0.117 to –0.04) 0.0006
High molecular weightc –0.064 (–0.101 to –0.028) 0.0019 –0.052 (–0.082 to –0.023) 0.0018
DEHP metabolitesd –0.066 (–0.113 to –0.018) 0.0100 –0.048 (–0.088 to –0.008) 0.0222
Potato MEP 0.100 (0.002 to 0.198) 0.0469 0.124 (0.012 to 0.235) 0.0318
Tomato MEP 0.148 (0.039 to 0.257) 0.0113 0.189 (0.056 to 0.321) 0.0083
MBzP –0.149 (–0.277 to –0.02) 0.0260 –0.147 (–0.285 to –0.009) 0.0382
Low molecular weightb 0.146 (0.038 to 0.253) 0.0112 0.187 (0.057 to 0.317) 0.0079
Total vegetable MEP 0.130 (0.063 to 0.197) 0.0009 0.142 (0.072 to 0.213) 0.0006
Low molecular weightb 0.125 (0.059 to 0.191) 0.0011 0.138 (0.068 to 0.207) 0.0008
  Total phthalates 0.061 (0.012 to 0.109) 0.0181 0.073 (0.021 to 0.125) 0.0094
CI, confidence interval. aAdjusted for BMI, age, ethnicity, and sex. bLow-molecular-weight phthalate metabolites (sum of MEP and MnMP). cHigh-molecular-weight phthalate metabo-
lites (sum of MECPP, MnBP, MCPP, MEHHP, MEHP, MiBP, MeOHP, and MBzP). dDEHP metabolites (sum of MECPP, MEHHP, MEHP, MEOHP).Colacino et al.
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2001, 2003). In the first study conducted in 
1999, 1­week duplicate diet samples were col­
lected for 63 patients in three hospitals from 
three geographically distinct prefectures in 
Japan (Tsumura et al. 2001). DEHP was also 
detected at the highest levels in these samples, 
with concentrations ranging from 10–4,400 
ng/g wet weight (ww). There was a signifi­
cant difference between mean levels of DEHP 
detected in the three hospitals, with two of 
the hospitals having considerably higher lev­
els (384 ng/g and 478 ng/g) compared with 
46 ng/g. The authors hypothesized that the 
elevated levels in two of the hospitals were due 
to the use of disposable PVC gloves, which 
used DEHP in manufacturing, during food 
preparation. In a follow­up study, Tsumura 
et al. (2003) examined levels of phthalates in 
duplicate diet samples that were collected in 
2001after the use of DEHP in PVC gloves 
was banned. Once again, the researchers col­
lected week­long duplicate diet samples from 
63 patients at the same 3 hospitals. DEHP 
levels in these samples were detected at signifi­
cantly lower levels than in the previous study, 
with a range of 6–675 ng/g ww compared 
with 10–4,400 ng/g ww in the previous study. 
The lower levels of phthalates detected in this 
study support the hypothesis of Tsumura 
et al. (2003) that the PVC gloves used in food 
prepara  tion were a substantial source of phtha­
lates in the total diet samples. The estimated 
daily average intake of DEHP was 160 µg/day. 
Nondetected levels in this study were esti­
mated using half of the detection limit, which 
ranged from 0.1–15.6 ng/g ww, which could 
overestimate the daily phthalate intake because 
of the high detection limit. Tsumura et al. 
(2003) also measured levels of other phtha­
lates whose metabolites were measured in the 
present study: di­n­butyl phthalate (DBP), 
benzylbutyl phthalate (BBP), dicyclohexyl 
phthalate (DCHP), and diisononyl phthalate 
(DINP). DBP was detected above the limit 
of quantification (LOQ) in 12 of 63 samples 
tested, with detected values ranging from 
4.5–27.1 ng/g ww. BBP was detected above 
the LOQ in 29 of 63 samples, with detected 
values ranging from 0.9 to 27.1 ng/g ww. 
DCHP was not quantified in any samples. 
DINP was detected above the LOQ in 2 of 
63 samples; one sample was 10 ng/g ww, the 
other 24 ng/g ww. The results of both stud­
ies suggested that diet is likely a significant 
route of exposure to phthalates (Tsumura et al. 
2001, 2003).
A study conducted in Denmark examined 
the levels of DEHP, DBP, and BBP in total 
diet samples, infant formula, and baby food 
(Petersen and Breindahl 2000). DEHP was 
detected in 11 of 29 total diet samples above 
the LOQ, with an estimated average concen­
tration in all samples ranging from 110 to 
180 ng/g ww. DBP was detected above the 
LOQ in 6 of 29 total diet samples, with an 
estimated average concentration in all sam­
ples ranging from 90–190 ng/g ww. BBP was 
detected above the LOQ in 8 of 29 diet sam­
ples, with an estimated average concentration 
in all samples ranging from 17–19 ng/g ww. 
Plasticizers were detected in 6 of 11 baby 
food samples tested as well as 8 of 11 infant 
formula samples. DEHP was measured at the 
highest levels in both individual baby food 
and infant formula samples, 0.63 µg/g ww 
and 0.06 µg/g ww, respectively. Overall, 
DEHP was estimated to be consumed at the 
highest levels through diet, with an estimated 
intake of 0.30 mg/day, whereas the estimated 
daily consumption of DBP was 0.29 mg/day 
and 0.03 mg/day for BBP.
Wormuth et al. (2006) explored routes 
of exposure of the European populations to 
phthalates via modeling. Potential routes con­
sidered in the study included consumption 
of contaminated food, ingestion of contam­
inated soil and dust, ingestion of personal 
care products containing phthalates, dermal 
exposure to personal care products, and inha­
lational exposure. The authors estimated that 
infants and small children were exposed at 
the highest levels to all of the eight differ­
ent phthalates studied when normalizing by 
body weight. The study found that dietary 
intake was the primary route of exposure to 
DEHP, DiBP, and DnBP. The main route of 
exposure to DEP was estimated to be dermal 
exposure to personal care products. This study 
emphasized the importance of dietary intake 
in total phthalate exposure as well as the wide 
range of routes that should be considered 
when assessing phthalate exposure.
The findings from our study suggest 
that there is an association between dietary 
consumption of certain food types and lev­
els of chemical contaminants measured in the 
NHANES study population. Poultry con­
sumption was significantly associated with cre­
atinine­adjusted DEHP metabolites MEHP, 
MEHHP, MEOHP, and MECPP as well as 
high­molecular­weight phthalate metabolites. 
Additionally, the finding that egg consump­
tion is significantly associated with levels of 
MEHP suggests that chickens themselves may 
be contaminated with phthalates and that 
food is not being contaminated just through 
packaging and processing. Fruit and vegetable 
consumption was associated with metabo­
lites of the low­molecular­weight phthalates, 
such as DEP and DMP. Fruit consumption 
was inversely associated with metabolites of 
high­molecular­weight phthalates and DEHP 
metabolites. DEP and DMP are much more 
water soluble than the higher weight phtha­
lates, which could explain their presence in 
fruit and vegetables (Stales et al. 1997). Meat 
intake was associated with the metabolite of 
DEP, but not with DEHP metabolites as 
poultry was. This finding suggests a potentially 
different source of contamination in poultry 
compared with meat. Routes of phthalate 
contamination for food could vary between 
food types, and could be from the food itself, 
during processing and packaging, or during 
storage. Because of this current uncertainty in 
sources of phthalate contamination in food, 
future studies of chemical contamination of 
U.S. food should involve experts from the food 
industry who could assist in determining at 
what step in the production process contami­
nation is occurring. Studying human exposure 
to phthalates is complicated by the difficulty 
in analyzing the parent compounds because 
of widespread environmental contamination, 
including contamination in laboratories, which 
makes determining how much of each phtha­
late is present in various products challenging. 
Additionally, various countries have differ­
ing regulations about how much phthalate is 
allowed in a product, which can complicate 
exposure estimation. We recently described a 
mixture of chemicals, many with unknown or 
incompletely described human toxicity, found 
in U.S. food (Schecter et al. 2009, 2010). The 
potential exists for additive, synergistic, or 
multiplicative toxic effects for chemicals found 
in food or food packaging, particularly for 
  endocrine­disrupting   compounds.
Although dietary intake was significantly 
associated with levels of phthalate metabolites 
measured in urine, dietary intake, as meas­
ured in this study, cannot solely explain all of 
phthalate body burden. The potential routes 
of phthalate exposure are diverse, because of 
the wide range of commercial uses of phtha­
lates. The main strengths of this study are the 
large sample sizes measured by NHANES, as 
well as the comprehensive data collected about 
each study participant that included both sur­
vey questions and chemical analyses of phtha­
late levels. The main weakness of the current 
approach is the cross­sectional design of the 
NHANES study, which makes determining 
causation impossible. Dietary intake in this 
study was estimated by a single 24­hr dietary 
recall that estimated the food consumed the 
day before urine was collected, and chemi­
cal levels were measured on only one occa­
sion. A follow­up study could bene  fit from 
multiple phthalate metabolite meas  urements 
to provide an average level. The possibility 
exists that these data may not be truly repre­
sentative of either dietary intake or chemical 
levels. However, the results from this study, 
combined with results from previous studies, 
suggest that the food supply is contaminated 
with phthalates, among other chemicals. A 
large study, possibly government sponsored, 
of chemical contamination of food is likely 
necessary to accurately assess the amount of 
and sources of contamination to protect the 
health of the public.Dietary intake predicts phthalate body burden
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